Relative increase of memory B-cell subsets under s.c. B-cell-depleting therapies in multiple sclerosis - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Increased Proportions of Memory B-Cell Subsets Observed in Multiple Sclerosis Patients Undergoing Subcutaneous B-Cell Depletion Therapies

  • By

  • Adriana Krenz

  • Anna-Lena Krickl

  • Felix Burner

  • David Freudenstein

  • Constantin Träger

  • Timo Wirth

  • Luisa Klotz

  • Klemens Angstwurm

  • De-Hyung Lee

  • Ralf A. Linker

  • Stefanie Haase

  • June 15, 2026

Share

Original Source(s)

Relative increase of memory B-cell subsets under s.c. B-cell-depleting therapies in multiple sclerosis

  • by Adriana Krenz, Anna-Lena Krickl, Felix Burner, David Freudenstein, Constantin Träger, Timo Wirth, Luisa Klotz, Klemens Angstwurm, De-Hyung Lee, Ralf A. Linker, Stefanie Haase

  • June 15, 2026

Related Content

Digging deeper into NINJ1: its multifaceted role in central nervous system diseases

Top 10 Evidence-Based Essentials in Neurology

A structured framework of guidelines, trials, therapies, and tools used in clinical practice.

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.